Similar Search Results

Productivity in Pharmaceutical Biotechnology R&D : The Role of Experience and Alliances

Danzon, Patricia Munch - 2003

Using data on over 900 firms for the period 1988-2000, we estimate the effect on phase-specific biotech and pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the diversification of its experience, and alliances with large and...

Persistent link: https://www.econbiz.de/10012469083

Present at the Revolution : Transformation of Technical Identity for a Large Incumbent Pharmaceutical Firm After the Biotechnological Breakthrough

Zucker, Lynne G. - 1995

profound, biotechnology applications in this large incumbent firm are more likely to be combined with other techno- logies than … in the new biotechnology firms (NBFs) which use biotechnology for both discovery and production of new therapeutic … more effective applications of the new technologies, but it could retard full adoption of biotechnology. It appears that …

Persistent link: https://www.econbiz.de/10012473634

Do Patents Matter? : Empirical Evidence after GATT

Lanjouw, Jean O. - 2000

Since the late 1980s the global intellectual property rights (IPR) system has been strengthening dramatically as much of the developing world introduces patent protection for new drug products. This may lead to more research on drugs to address developing country needs. As there are identifiable...

Persistent link: https://www.econbiz.de/10012471281

Are National Patent Laws the Blossoming Rain?

Qian, Yi - 2010

By thoroughly controlling for the country covariates, through a combination of matched sampling techniques with fixed-effect panel regression models, the analyses arrive at robust results across the various model specifications. First, national pharmaceutical patent protection alone does not...

Persistent link: https://www.econbiz.de/10012462357

Investments in Pharmaceuticals Before and After TRIPS

Kyle, Margaret - 2009

We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the...

Persistent link: https://www.econbiz.de/10012463181

The Dual Effects of Intellectual Property Regulations : Within- and Between- Patent Competition in the US Pharmaceuticals Industry

Lichtenberg, Frank R. - 2002

A patent only protects an innovator from others producing the same product, but it does not protect him from others producing better products under new patents. Therefore, one may divide up the source of competition facing an innovator into within-patent competition, which results from...

Persistent link: https://www.econbiz.de/10012469403

The Introduction of Pharmaceutical Product Patents in India : "Heartless Exploitation of the Poor and Suffering"?

Lanjouw, Jean O. - 1998

The decision to require that countries grant product patents for pharmaceutical innovations as a condition of membership in the World Trade Organization was very contentious. Almost 50 developing countries were not granting patent monopolies for drugs during the period the Uruguay round of GATT...

Persistent link: https://www.econbiz.de/10012472451

Cross-National Evidence on Generic Pharmaceuticals : Pharmacy vs. Physician-Driven Markets

Danzon, Patricia Munch - 2011

This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the...

Persistent link: https://www.econbiz.de/10012461428

Patents as Options : Some Estimates of the Value of Holding European Patent Stocks

Pakes, Ariel - 1984

In many countries holders of patents must pay an annual renewal fee in order to keep their patents in force. This paper uses data on the proportion of patents renewed, and the renewal fees faced by, post World War II cohorts of patents in France, the United Kingdom, and Germany, in conjunction...

Persistent link: https://www.econbiz.de/10012477754

How Do Patent Laws Influence Innovation? Evidence from Nineteenth-Century World Fairs

Moser, Petra - 2003

This paper introduces a new internationally comparable data set that permits an empirical investigation of the effects of patent law on innovation. The data have been constructed from the catalogues of two 19th century world fairs: the Crystal Palace Exhibition in London, 1851, and the...

Persistent link: https://www.econbiz.de/10012468788

1
2
3
4
5
6
7
8
9
10
Next
Last